tiprankstipranks
Trending News
More News >
Seres Therapeutics (MCRB)
NASDAQ:MCRB
US Market
Advertisement

Seres Therapeutics (MCRB) Technical Analysis

Compare
1,071 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Seres Therapeutics’s (MCRB) Moving Averages Convergence Divergence (MACD) indicator is 0.95, suggesting Seres Therapeutics is a Buy.
Seres Therapeutics’s (MCRB) 20-Day exponential moving average is 13.49, while Seres Therapeutics’s (MCRB) share price is $15.29, making it a Buy.
Seres Therapeutics’s (MCRB) 50-Day exponential moving average is 11.96, while Seres Therapeutics’s (MCRB) share price is $15.29, making it a Buy.

Seres Therapeutics (MCRB) Pivot Points

Aug 08, 2025, 03:09 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
11.10
12.31
13.04
14.25
14.98
16.19
16.92
Fibonacci
12.31
13.05
13.51
14.25
14.99
15.45
16.19
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Seres Therapeutics (MCRB) Moving Averages

Aug 08, 2025, 03:09 PM
Period
Simple
Exponential
MA5
14.42Buy
14.47Buy
MA10
14.07Buy
14.15Buy
MA20
13.88Buy
13.49Buy
MA50
10.82Buy
11.96Buy
MA100
10.65Buy
11.79Buy
MA200
13.34Buy
13.62Buy
Seres Therapeutics’s (MCRB) 10-Day exponential moving average is 14.15, while Seres Therapeutics’s (MCRB) share price is $15.29, making it a Buy.
Seres Therapeutics’s (MCRB) 100-Day exponential moving average is 11.79, while Seres Therapeutics’s (MCRB) share price is $15.29, making it a Buy.
Seres Therapeutics’s (MCRB) stock price is $15.29 and Seres Therapeutics’s (MCRB) 50-day simple moving average is 10.82, creating a Buy signal.
Seres Therapeutics’s (MCRB) stock price is $15.29 and Seres Therapeutics’s (MCRB) 100-day simple moving average is 10.65, creating a Buy signal.
Seres Therapeutics’s (MCRB) stock price is $15.29 and Seres Therapeutics’s (MCRB) 200-day simple moving average is 13.34, creating a Buy signal.

Seres Therapeutics (MCRB) Technical Indicators

Aug 08, 2025, 03:09 PM
Name
Value
Implied Action
RSI (14)
61.71
Neutral
STOCH (9,6)
65.72
Neutral
STOCHRSI (14)
73.57
Neutral
MACD (12,26)
0.95
Buy
ADX (14)
35.01
Neutral
Williams %R
-13.93
Sell
CCI (14)
133.39
Sell
ATR (14)
1.42
-
Ultimate Oscillator
52.30
Neutral
ROC
8.67
Buy
Seres Therapeutics’s (MCRB) Relative Strength Index (RSI) is 61.71, creating a Neutral signal.
Seres Therapeutics’s (MCRB) Trend Strength Indicator (ADX) is 35.01, creating a Neutral signal.
Seres Therapeutics’s (MCRB) Commodity Channel Index (CCI) is 133.39, creating a Sell signal.
Seres Therapeutics’s (MCRB) Price Rate of Change (ROC) is 8.67, creating a Buy signal.

FAQ

Is MCRB a Buy, Hold, or Sell?
Based on MCRB’s technical indicators, MCRB is a Strong Buy.
    What is MCRB’s RSI (14)?
    MCRB’s RSI (14) is 61.71, which suggests MCRB is a Neutral.
      What is MCRB’s MACD?
      MCRB’s MACD is 0.95, which suggests MCRB is a Buy.
        What is MCRB’s 5-day moving average?
        MCRB’s 5-day moving average is 14.42, which suggests MCRB is a Buy.
          What is MCRB’s 20-day moving average?
          MCRB 20-day moving average is 13.88, which suggests MCRB is a Buy.
            What is MCRB’s 50-day moving average?
            MCRB’s 50-day moving average is 10.82, which suggests MCRB is a Buy.
              What is MCRB’s 200-day moving average?
              MCRB’s 200-day moving average is 13.34, which suggests MCRB is a Buy.
                What is MCRB’s Williams % R (14)?
                MCRB’s Williams % R (14) is -13.93, which suggests MCRB is a Sell.
                  What is MCRB’s CCI (14)?
                  MCRB’s CCI (14) is 133.39, which suggests MCRB is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis